Inspiration Biopharmaceuticals has announced the positive preclinical safety, toxicology and preliminary pharmacokinetic data on IB1001. Its a novel recombinant Factor IX product intended to treat patients with hemophilia
ALDA has received US Patent Number 7560422 from US Patent and Trademark Office (USPTO). The patent is a continuation of US Patent Number 7338927 that was issued on
AmexDrug has launched two topical creams – Sponix Arthritis Muscle & Pain Relief Cream and Sponix Tired Feet & Legswhich, which provide relief on contact. Sponix Arthritis and
Onset Therapeutics has launched Hylatopic Emollient Foam, a non-steroidal prescription product. It is indicated to manage and relieve the burning, itching and pain experienced with various types of
Keryx has initiated phase 1 clinical study to evaluate KRX-0401 (perifosine) as a single agent treatment for recurrent solid tumors in pediatric patients. KRX-0401 is an oral, anticancer
Can-Fite is going to initiate phase I/II clinical trial with CF102 for the treatment of Hepatitis C Virus (HCV), following the approval by the Israel Ministry of Health
Noven has reported positive top-line results from its phase 2 clinical study evaluating Mesafem (low-dose paroxetine mesylate). It is intended for the treatment of vasomotor symptoms (hot flashes)
The Chilean Ministry of Health has approved Wyeth’ Prevenar 13 Valent, (Diphtheria CRM197 Protein) for infants and young children. Prevenar 13 Valent is approved for immunization of children
Yissum has licensed a novel package of stem cell related technologies to TheraCell. TheraCell would further develop and commercialize the technology for advanced regenerative medicine procedures, such as
Cystic fibrosis is a devastating hereditary chronic disease typically diagnosed in children before the age of two and is marked by mucus build-up and clogging of key organs
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.